• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 26, 2023

    9/26/23 5:30:08 PM ET
    $ACB
    $CARA
    $CRBP
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACB alert in real time by email

    GAINERS:

    • GreenGro Technologies (OTC:GRNH) shares closed up 28.89% at $0.00
    • Rocky Mountain High (OTC:RMHB) shares closed up 18.75% at $0.01
    • iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 9.72% at $0.03
    • Target Group (OTC:CBDY) shares closed up 9.07% at $0.01
    • Urban-gro (NASDAQ:UGRO) shares closed up 8.46% at $1.41
    • Trulieve Cannabis (OTC:TCNNF) shares closed up 7.50% at $6.74
    • Kaya Holdings (OTC:KAYS) shares closed up 6.73% at $0.05
    • Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed up 6.11% at $6.43
    • 4Front Ventures (OTC:FFNTF) shares closed up 5.96% at $0.25
    • Global Hemp Group (OTC:GBHPF) shares closed up 5.56% at $0.00
    • Cara Therapeutics (NASDAQ:CARA) shares closed up 4.68% at $1.79
    • RIV Capital (OTC:CNPOF) shares closed up 4.55% at $0.12
    • MJ Holdings (OTC:MJNE) shares closed up 4.00% at $0.02
    • Emeren Group (NYSE:SOL) shares closed up 3.83% at $2.98
    • Green Thumb Industries (OTC:GTBIF) shares closed up 3.36% at $11.08

    LOSERS:

    • Choom Holdings (OTC:CHOOF) shares closed down 99.00% at $0.00
    • Heritage Cannabis Holding (OTC:HERTF) shares closed down 23.73% at $0.01
    • Nextleaf Solutions (OTC:OILFF) shares closed down 13.82% at $0.05
    • Pharmadrug (OTC:LMLLF) shares closed down 13.36% at $0.01
    • 1933 Industries (OTC:TGIFF) shares closed down 12.35% at $0.01
    • Trees (OTC:CANN) shares closed down 10.41% at $0.15
    • Charlottes Web Holdings (OTC:CWBHF) shares closed down 9.10% at $0.36
    • Cansortium (OTC:CNTMF) shares closed down 9.09% at $0.10
    • Tilray Brands (NASDAQ:TLRY) shares closed down 6.61% at $2.40
    • Maple Leaf Green World (OTC:MGWFF) shares closed down 6.45% at $0.03
    • Zelira Therapeutics (OTC:ZLDAF) shares closed down 5.72% at $0.64
    • BioHarvest Sciences (OTC:CNVCF) shares closed down 5.50% at $0.13
    • Aurora Cannabis (NASDAQ:ACB) shares closed down 5.32% at $0.70
    • Leafbuyer Techs (OTC:LBUY) shares closed down 4.99% at $0.06
    • Village Farms Intl (NASDAQ:VFF) shares closed down 4.86% at $0.86
    • CLS Holdings USA (OTC:CLSH) shares closed down 4.81% at $0.05
    • SNDL (NASDAQ:SNDL) shares closed down 4.33% at $1.99
    • Neptune Wellness Solns (NASDAQ:NEPT) shares closed down 4.26% at $1.35
    • Eastside Distilling (NASDAQ:EAST) shares closed down 3.67% at $1.31
    • Cannabix Technologies (OTC:BLOZF) shares closed down 3.51% at $0.22
    • OrganiGram Holdings (NASDAQ:OGI) shares closed down 3.38% at $1.43
    • GrowGeneration (NASDAQ:GRWG) shares closed down 3.38% at $2.86
    • Encompass Health (NYSE:EHC) shares closed down 3.27% at $67.77
    • Greenlane Hldgs (NASDAQ:GNLN) shares closed down 3.25% at $0.71
    • Cronos Group (NASDAQ:CRON) shares closed down 3.21% at $2.11
    • Body and Mind (OTC:BMMJ) shares closed down 3.14% at $0.08
    • Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed down 3.03% at $1.28

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB
    $CARA
    $CRBP
    $CRON

    CompanyDatePrice TargetRatingAnalyst
    Tilray Brands Inc.
    $TLRY
    1/27/2026Hold
    Canaccord Genuity
    Aurora Cannabis Inc.
    $ACB
    1/27/2026Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Cronos Group Inc.
    $CRON
    1/27/2026Buy
    Canaccord Genuity
    SNDL Inc.
    $SNDL
    9/3/2025$5.00Buy
    Alliance Global Partners
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2025$28.00Buy
    B. Riley Securities
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    2/28/2025Outperform
    William Blair
    Aurora Cannabis Inc.
    $ACB
    12/11/2024Buy
    TD Cowen
    More analyst ratings

    $ACB
    $CARA
    $CRBP
    $CRON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SNDL to Report Fourth Quarter 2025 and Full Year 2025 Financial Results on March 12, 2026

    EDMONTON, Alberta, Feb. 19, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2025 financial results for the period ended December 31, 2025, before markets open on Thursday, March 12, 2026. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 12, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/aps8jm4e ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integr

    2/19/26 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    Encompass Health declares dividend on common stock

    BIRMINGHAM, Ala., Feb. 19, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.19 per share, payable on April 15, 2026, to holders of record on April 1, 2026. About Encompass HealthEncompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 173 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients rec

    2/19/26 8:44:00 AM ET
    $EHC
    Hospital/Nursing Management
    Health Care

    Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group

    Organigram shares priced at average C$2.72 per share representing a combination of Top-Up Rights being exercised at C$2.34/share and shares issued in connection with Sanity acquisition priced at C$3.00/share. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading global cannabis company, today announced that it has entered into a subscription agreement (the "Subscription Agreement") with BT DE Investments Inc. ( "BAT"), a wholly-owned subsidiary of British American Tobacco p.l.c. (NYSE:BTI), in connection with its previously announced proposed acquisition (the "Acquisition") of Sanity Group GmbH ("Sanity" or "Sanity Group"), including shares of Sanity ow

    2/19/26 6:00:00 AM ET
    $BTI
    $OGI
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ACB
    $CARA
    $CRBP
    $CRON
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    SEC Filings

    View All

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    2/20/26 4:58:07 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: Encompass Health Corporation filed SEC Form 8-K: Leadership Update

    8-K/A - Encompass Health Corp (0000785161) (Filer)

    2/20/26 4:20:19 PM ET
    $EHC
    Hospital/Nursing Management
    Health Care

    urban-gro Inc. filed SEC Form 8-K: Leadership Update

    8-K - urban-gro, Inc. (0001706524) (Filer)

    2/19/26 4:58:18 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $ACB
    $CARA
    $CRBP
    $CRON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Aiello Stephen bought $221,334 worth of shares (133,334 units at $1.66), increasing direct ownership by 25% to 668,311 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    9/23/25 4:00:54 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    Global General Counsel Gendel Mitchell exercised 93,928 shares at a strike of $0.58, covered exercise/tax liability with 49,782 shares and bought $3,496 worth of shares (6,000 units at $0.58), increasing direct ownership by 8% to 698,287 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:06:19 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    President and CEO Simon Irwin D bought $100,106 worth of shares (165,000 units at $0.61), increasing direct ownership by 4% to 3,941,633 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/30/25 6:52:32 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Charbonneau Elissa Joy covered exercise/tax liability with 4,303 units of Encompass Health Common Stock, decreasing direct ownership by 19% to 18,453 units (SEC Form 4)

    4 - Encompass Health Corp (0000785161) (Issuer)

    2/23/26 3:42:07 PM ET
    $EHC
    Hospital/Nursing Management
    Health Care

    President & CEO Tarr Mark J covered exercise/tax liability with 45,175 units of Encompass Health Common Stock, decreasing direct ownership by 9% to 445,637 units (SEC Form 4)

    4 - Encompass Health Corp (0000785161) (Issuer)

    2/23/26 3:40:41 PM ET
    $EHC
    Hospital/Nursing Management
    Health Care

    Sr. Vice Pres. and Treasurer Fay Edmund covered exercise/tax liability with 3,687 units of Encompass Health Common Stock, decreasing direct ownership by 3% to 101,922 units (SEC Form 4)

    4 - Encompass Health Corp (0000785161) (Issuer)

    2/23/26 3:39:23 PM ET
    $EHC
    Hospital/Nursing Management
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Tilray

    Canaccord Genuity initiated coverage of Tilray with a rating of Hold

    1/27/26 9:29:20 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Cronos Group

    Canaccord Genuity initiated coverage of Cronos Group with a rating of Buy

    1/27/26 9:29:20 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    Leadership Updates

    Live Leadership Updates

    View All

    Greenlane Appoints Jason Hitchcock as Chief Executive Officer to Advance Digital Asset Treasury Strategy

    BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN) today announced the appointment of Jason Hitchcock as its Chief Executive Officer, effective immediately. Mr. Hitchcock is a technology executive with over 15 years of experience building and scaling revenue engines across SaaS, blockchain infrastructure, and decentralized finance. He joins Greenlane as the Company continues to execute its Berachain-focused Digital Asset Treasury ("DAT") strategy, combining disciplined capital allocation with active ecosystem participation through validator operations, staking, and liquidity provisioning. Technology Leadership and Ent

    2/18/26 8:00:00 AM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois

    BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), has announced appointment of Romano Beverage, a respected partner, to manage distribution responsibilities within the state. Romano Beverage, a trusted leader in beverage distribution, is now overseeing Breckenridge Distillery's full spirits collection across Illinois—including its celebrated bourbon whiskey, whiskey, rum, vodka, gin, and newly launched Mountain Shot. Romano's strong presence in Illinois and dedication to exceptional service make them the perfect partner to help Breckenridge Distillery thr

    2/4/26 8:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Encompass Health appoints Cain Hayes to its board of directors

    BIRMINGHAM, Ala., Feb. 2, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced the appointment of Cain A. Hayes to its board of directors. Hayes joins the Encompass Health board with significant experience in health care, strategic leadership, human capital management, risk management and governmental regulation. He retired as president and chief executive officer of Point32Health, Inc., a top-20 U.S. health plan, in 2024. Prior to joining Point32Health in 2021, he served as president and chief executive officer of Gateway Health Plan, Inc., following a long

    2/2/26 8:00:00 AM ET
    $EHC
    Hospital/Nursing Management
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G/A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 7:48:14 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 6:41:20 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    Financials

    Live finance-specific insights

    View All

    SNDL to Report Fourth Quarter 2025 and Full Year 2025 Financial Results on March 12, 2026

    EDMONTON, Alberta, Feb. 19, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2025 financial results for the period ended December 31, 2025, before markets open on Thursday, March 12, 2026. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 12, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/aps8jm4e ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integr

    2/19/26 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    Encompass Health declares dividend on common stock

    BIRMINGHAM, Ala., Feb. 19, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.19 per share, payable on April 15, 2026, to holders of record on April 1, 2026. About Encompass HealthEncompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 173 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients rec

    2/19/26 8:44:00 AM ET
    $EHC
    Hospital/Nursing Management
    Health Care

    Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

    TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be arch

    2/12/26 7:30:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary